ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1531

Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year

Michael Ziegelasch1, Kristina Forslind2, Thomas Skogh3, Katrine Riklund4, Alf Kastbom5 and E. Berglin6, 1Rheumatology/AIR, Linköping, Sweden, 2Department of Medicine, Helsingborgs Lasarett, Section of Rheumatology, Helsingborg, Sweden, 3IKE/Rheumatology, Linköping University, Linköping, Sweden, 4Departments of Diagnostic radiology, Umeå university, Umeå, Sweden, 5Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping, Sweden, 6Department of Publiic Health and Clinical Medicin/Rheumatology, Umeå university, Umea, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bone density, radiography, rheumatoid arthritis (RA) and x-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Digital X-ray radiogrammetry (DXR) is a method to calculate peripheral bone mineral density (BMD) which calculates BMD of the hands (DXR-BMD). The aim of this study was to evaluate whether hand bone loss (HBL) during the initial three months after diagnosis predicts radiographic joint damage after 12 and 24 months in patients with rheumatoid arthritis (RA).

Methods:   Patients with early RA (<12 months since symptom onset) were consecutively included from three Swedish rheumatology departments (and treated according to the Swedish guidelines). Radiographs of hands and feet were taken at baseline, 3 months (hands only), 12 and 24 months. The baseline, 12 and 24 months radiographs were evaluated according to the Larsen score by one reader at each centre. The smallest detectable change (SDC) was established for each reader individually. DXR-BMD was performed on radiographs of the hands taken at baseline and after 3 months. Changes in BMD were evaluated in metacarpals 2, 3 and 4. HBL was defined either as a moderate change in DXR-BMD (≥0,25 but <2,5 mg/cm2 per month) or a severe change (≥2,5 mg/cm2 per month), as defined by the device manufacturer Sectra AB, Sweden. Radiographic progression was defined as a difference in Larsen score above the SDC [of the corresponding reader]. Statistical calculations were performed using SPSS 23 software. After testing different variables in a simple regression with change in Larsen score as dependent variable, all variables with the lowest p-value (p<0.2) were extracted to perform univariate analysis of variance. ESR and anti-CCP were measured at baseline and DAS28 was evaluated at each visit.

Results:   One hundred and sixty seven patients (64% women) with a mean disease duration of 6 months (SD 3.7) and mean age 58 years (SD 14.5) were included. 63% tested positive regarding serum anti-CCP antibodies. HBL occurred in 58.7% of the patients (44.3% moderate and 14.4% severe HBL). Thirty two patients (19.2%) had radiographic progression at 12 months and 45 (34.9%) at 24 months. Greater HBL within 3 months associated significantly (p= 0.033) with greater increase in Larsen score between baseline and 12 months, adjusted for sex and baseline values of ESR, DAS28, Larsen score and anti-CCP status. No significant association was observed between early bone loss and radiological damage at 24 months (p=0.626).  

Conclusion:   HBL during the initial three months is an independent predictor of radiologic joint damage at 12 months in patients with early RA, but does not predict the 24 months outcome. Thus, DXR-BMD examinations after three months may be useful to detect ongoing joint damage, but the long-term predictive ability seems to be limited.


Disclosure: M. Ziegelasch, None; K. Forslind, None; T. Skogh, None; K. Riklund, None; A. Kastbom, BMS, Roche, UCB, 5; E. Berglin, None.

To cite this abstract in AMA style:

Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E. Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/decrease-in-bone-mineral-density-during-three-months-of-early-ra-measured-by-dxr-predicts-radiographic-joint-damage-after-one-year/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decrease-in-bone-mineral-density-during-three-months-of-early-ra-measured-by-dxr-predicts-radiographic-joint-damage-after-one-year/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology